Literature DB >> 19165650

The effects of a vitality training programme on psychological distress in patients with inflammatory rheumatic diseases and fibromyalgia: a 1-year follow-up.

H A Zangi, A Finset, E Steen, P Mowinkel, K B Hagen.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19165650     DOI: 10.1080/03009740802474680

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  5 in total

Review 1.  Awakening is not a metaphor: the effects of Buddhist meditation practices on basic wakefulness.

Authors:  Willoughby B Britton; Jared R Lindahl; B Rael Cahn; Jake H Davis; Roberta E Goldman
Journal:  Ann N Y Acad Sci       Date:  2013-12-26       Impact factor: 5.691

2.  Effects of a one week multidisciplinary inpatient self-management programme for patients with fibromyalgia: a randomised controlled trial.

Authors:  Bente Hamnes; Petter Mowinckel; Ingvild Kjeken; Kåre B Hagen
Journal:  BMC Musculoskelet Disord       Date:  2012-09-26       Impact factor: 2.362

3.  Emotion regulation in patients with rheumatic diseases: validity and responsiveness of the Emotional Approach Coping Scale (EAC).

Authors:  Heidi A Zangi; Andrew Garratt; Kåre Birger Hagen; Annette L Stanton; Petter Mowinckel; Arnstein Finset
Journal:  BMC Musculoskelet Disord       Date:  2009-09-03       Impact factor: 2.362

4.  Effects of a mindfulness-based and acceptance-based group programme followed by physical activity for patients with fibromyalgia: a randomised controlled trial.

Authors:  Trond Haugmark; Kåre Birger Hagen; Sella Aarrestad Provan; Geir Smedslund; Heidi A Zangi
Journal:  BMJ Open       Date:  2021-06-29       Impact factor: 2.692

5.  Effects of a community-based multicomponent rehabilitation programme for patients with fibromyalgia: protocol for a randomised controlled trial.

Authors:  Trond Haugmark; Kåre Birger Hagen; Sella Aarrestad Provan; Elisebeth Bærheim; Heidi A Zangi
Journal:  BMJ Open       Date:  2018-06-04       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.